• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Abbott India Ltd Pharmaceuticals - Multinational

  • MNC Asc-Abbott
  • BSE Code : 90.0
  • ISIN : INE358A01014
30,720.55 151 (0.50%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    30,420.10

  • Today’s High

    30,800.00

  • Open

    30,570.00

  • Perv Close

    30,569.15

  • 52W Low

    25,200.00

  • 52W High

    31,898.95

Key Indicators

  • P/E(TTM)

    48.94

  • Mar.Cap (₹Cr.)

    65,281.17

  • Div & Yield %

    1.33

  • Book Value(₹)

    1,656.99

  • Debt-Equity Ratio

    0.50

  • AGM Date

    28-Mar-2025

  • EPS

    627.98

  • P/E Ratio

    48.94

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    65,281.17

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    21.25

  • BV (₹)

    1,657.00

  • Sales( ₹ in Cr.)

    5,875.26

  • NP (in Cr.)

    1,201.10

  • NP Var(%)

    26.0

  • Div%

    4100.0

  • CPS (₹)

    598.70

  • EPS (₹)

    565.20

  • Traded Value (₹ in Lakhs)

    65,302.63

  • 52 Week High

    31,898.95

  • 52 Week Low

    25,200.00

  • Price BSE

    30731.0

  • Price NSE

    30,721.00

  • Market Capital( in Cr.)

    65,302.63

  • P/C Ratio

    51.30

  • P/E Ratio

    54.40

  • Price Vs.BV

    565.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 5,848.91 5,348.73 4,913.32 4,310.02 4,093.14 3,678.60
Excise Duty 5,779.83 5,284.86 4,848.99 4,249.11 4,054.47 3,640.30
Net Sales 5,848.91 5,348.73 4,913.32 4,310.02 4,093.14 3,678.60
Other Income 248.27 154.15 83.16 80.90 114.39 113.29
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 6,097.18 5,502.88 4,996.48 4,390.92 4,207.53 3,791.89
EXPENDITURE :
Raw Materials 5,779.83 5,284.86 4,848.99 4,249.11 4,054.47 3,640.30
Power & Fuel Cost 5,779.83 5,284.86 4,848.99 4,249.11 4,054.47 3,640.30
Employee Cost 576.58 563.59 579.46 492.65 476.11 435.58
Other Manufacturing Expenses 51.98 69.92 80.15 75.61 81.11 64.36
Selling & Administrative Expenses 403.54 437.39 439.93 366.98 400.27 432.83
Miscellaneous Expenses 51.98 69.92 80.15 75.61 81.11 64.36
Less : Pre-operative Expenses Capitalised :
Total Expenditure 4,479.43 4,229.06 3,916.75 3,464.97 3,404.83 3,093.03
Operating Profit 143.10 97.14 74.80 62.40 63.57 52.50
Interest 12.45 15.99 19.10 18.28 8.53 2.25
Gross Profit 1,617.75 1,273.82 1,079.73 925.95 802.70 698.85
Depreciation 71.17 69.97 66.10 58.13 59.61 16.92
Profit Before Tax 1,617.75 1,273.82 1,079.73 925.95 802.70 698.85
Tax 415.43 329.41 276.98 242.76 208.04 248.46
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.07 -1.19 -0.13 -3.79 1.48 2.65
Reported Net Profit 1,201.22 949.41 798.70 690.69 592.93 450.33
Extraordinary Items 1,617.75 1,273.82 1,079.73 925.95 802.70 698.85
Adjusted Net Profit 1,201.22 949.41 798.70 690.69 592.93 450.33
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 871.22 690.60 584.35 584.36 531.23 138.12
P & L Balance carried down 1,201.22 949.41 798.70 690.69 592.93 450.33
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 4,100.00 3,250.00 2,750.00 2,750.00 2,500.00 650.00
Dividend Per Share(Rs) 410.00 325.00 275.00 275.00 250.00 65.00
Earnings Per Share-Unit Curr 565.30 446.80 375.87 325.04 279.04 211.93
Book Value 871.22 690.60 584.35 584.36 531.23 138.12
Book Value(Adj)-Unit Curr 871.22 690.60 584.35 584.36 531.23 138.12

Shareholding Pattern

  • Promoter Group

    74.99%

  • Public Share Holding

    25.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 15,934,048 74.99 15,934,048 3
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 15,934,048 74.99 15,934,048 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 13,884 0.07 13,626 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 34,602 0.16 34,602 12
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 230,237 1.08 230,237 18
Mutual Funds / UTI 1,652,041 7.77 1,651,991 34
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 17,672 0.08 17,672 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,948,436 9.17 1,948,128 78
2] Non Institution
Bodies Corporate 142,447 0.67 142,357 863
Clearing Members 0 0.00 0 0
Directors of their Relatives 4 0.00 4 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 144,485 0.68 142,558 1,386
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 41,742 0.20 41,742 2
Individuals holding nominal share capital up to Rs. 1 lakh 2,846,429 13.40 2,669,592 64,020
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 191,711 0.90 191,711 1,539
Sub Total 3,366,818 15.84 3,187,964 67,811
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,249,302 100.00 21,070,140 67,892

Company Background

Abbott India LtdPharmaceuticals - Multinational

  • Abbott India Ltd
  • BSE Code : 90.0
  • ISIN : INE358A01014

  • Incorporation Year

    1944

  • Registered Office

    Unit No 3 Corporate Park
    Sion Trombay Road Chembur, Mumbai,
    Maharashtra-400071

  • Telephone

    91-22-67978888/50461000/2000/1119

  • FAX

    91-22-50169400

  • Chairman

    Munir Shaikh

  • Managing Director

    SWATI ROHAN DALAL

  • Company Secretary

  • Auditor

    S R B C & Co LLP/Walker Chandiok & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Abbott India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Novartis India 785.05 396.75 335.07 22.47 15.57
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92